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Abstract
Background: Combination oral contraceptive (COC) is the most common method of contraception utilized
in the United States. Currently, the traditional 28-day cyclic COC is the most popular. The newly developed
continuous COC shows multiple advantages over the traditional cyclic COC, both in reducing the frequency
of menses and the severity of associated symptoms, as well as providing the lifestyle benefits and convenience
for women. This systematic review evaluates the effect of continuous COC use on subsequent fertility in
healthy women of child-bearing age.
Method: An extensive search of MEDLINE, CINAHL, and Evidence Based Medicine Review Multifile was
conducted using fertility and oral contraceptives as key words. Articles written in the English language between
1990 and the present with human subjects were included. The GRADE system was utilized to assess the
quality of each study.
Results: Two studies were included in this systematic review. For women who had discontinued continuous
COC for pregnancy intent, the pregnancy rate at 12 months was 81%, comparable to the pregnancy rate of
women with previous traditional cyclic COC use. The median time to return of spontaneous menses after
cessation of continuous COC use was 1 month. These studies seem to indicate that continuous COC use does
not delay the time to fertility. However, the studies utilized were both of very low quality.
Conclusion: Based on current research, continuous COC has a good safety and efficacy profile. Recent
studies point towards lack of delay in return to fertility; however, more high quality research is necessary to
ascertain the effect of continuous COC use on subsequent fertility. At this time, women should be educated
about the limitations of current research to make their own decisions in choosing continuous COC as a
contraceptive method.
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Abstract   
 
Background:  Combination oral contraceptive (COC) is the most common method of 
contraception utilized in the United States. Currently, the traditional 28-day cyclic COC 
is the most popular. The newly developed continuous COC shows multiple advantages 
over the traditional cyclic COC, both in reducing the frequency of menses and the 
severity of associated symptoms, as well as providing the lifestyle benefits and 
convenience for women. This systematic review evaluates the effect of continuous COC 
use on subsequent fertility in healthy women of child-bearing age.  
Method:  An extensive search of MEDLINE, CINAHL, and Evidence Based Medicine 
Review Multifile was conducted using fertility and oral contraceptives as key words. 
Articles written in the English language between 1990 and the present with human 
subjects were included. The GRADE system was utilized to assess the quality of each 
study.  
Results:  Two studies were included in this systematic review. For women who had 
discontinued continuous COC for pregnancy intent, the pregnancy rate at 12 months was 
81%, comparable to the pregnancy rate of women with previous traditional cyclic COC 
use. The median time to return of spontaneous menses after cessation of continuous COC 
use was 1 month.  These studies seem to indicate that continuous COC use does not delay 
the time to fertility. However, the studies utilized were both of very low quality.  
Conclusion:  Based on current research, continuous COC has a good safety and efficacy 
profile. Recent studies point towards lack of delay in return to fertility; however, more 
high quality research is necessary to ascertain the effect of continuous COC use on 
subsequent fertility. At this time, women should be educated about the limitations of 
current research to make their own decisions in choosing continuous COC as a 
contraceptive method.  
Keywords: continuous oral contraceptives, time to pregnancy, return to fertility 
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The Effect of Continuous Combination Oral Contraceptive use  
on Subsequent Fertility 
BACKGROUND 
 In the United States, more than 99% of women of child-bearing age who have 
been sexually active have used at least one contraceptive method.1 The combination oral 
contraceptive (COC), also known as the Pill, was developed in 1960.2 This reversible 
form of contraceptive is the leading method in the United States.1 Since its development, 
the 28-day cycle COC has been the mainstay. The traditional cyclic 28-day COC, 
containing 21 active pills and 7 placebo pills, was designed to simulate the monthly 
menstrual cycle; however, this menstruation is not natural.2 The bleeding that occurs 
during the hormone-free interval is not due to the endometrial build-up, but rather due to 
the hormone withdrawal.3 The decision for this 28-day design was based on social 
pressure for naturalness and acceptance by women rather than on any biological 
evidence.2  
 In the twenty-first century, continuous COC became available. Continuous COC 
use is defined as when a pill is taken daily without a pill-free or a placebo period. The 
traditional 28-day cyclic COC produces significant withdrawal symptoms during the 
placebo period similar to the symptoms related to menstruation including headaches, 
bloating, pelvic pain, and breast-tenderness.4 In comparison, continuous COC will induce 
cycle suppression and amenorrhea in most women.5 Therefore, continuous COC may be 
preferred over the traditional cyclic COC for the reduction in the frequency of menses 
and the severity of associated symptoms. Women may also favor continuous COC for 
lifestyle benefits and convenience.5 Potential advantages include “less interference of 
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daily activities or special events, decreased expense for feminine hygiene products, and 
less menstruation-related absenteeism from work or school.”6  
Recently, a large phase 3 contraceptive trial has demonstrated that continuous 
COC containing Levonorgestrel (LNG) and Ethinyl estradiol (EE) has a good safety 
profile and efficacy comparable to the cyclic COC. The efficacy was demonstrated by the 
inhibition of menses through the induction of amenorrhea and the absence of bleeding 
and spotting.7 However, this trial did not examine the effect of continuous COC use on 
subsequent fertility. For some women, the fear of adverse effect on subsequent fertility 
following continuous COC use is an important concern. This systematic review evaluates 
the literature that addresses the effect of previous continuous COC use on the return to 
fertility in healthy women of child-bearing age.  
METHODS 
Search Strategy  
 A comprehensive electronic search of MEDLINE, CINAHL, and Evidence-Based 
Medicine Review Multifile was conducted to identify all relevant studies published 
between January 1, 1990 and present. The combined search terms used were: fertility, 
and oral contraceptives. Articles were included if they evaluated the effect of continuous 
COC use on subsequent fertility in healthy women of child-bearing age. The return to 
fertility after the cessation of continuous COC was measured utilizing either the return to 
spontaneous menses or time to pregnancy. The exclusion criteria entailed articles 
assessing the traditional cyclic COC or the use of COC for therapeutic purposes. The 
search was restricted to English language reports and human subjects. In addition to the 
 9 
electronic database search, the reference lists of all identified publications were examined 
for previously unidentified articles.    
Quality Assessment 
 The included articles were critically appraised for validity and quality using the 
GRADE system.8 The following factors were examined: study design, limitation of the 
methodology, consistency of the results, directness of the evidence, precision of the 
results, and possible publication bias. Each study was categorized into high, medium, 
low, or very low quality of evidence. The characteristics and the quality assessment of 
these studies are shown in Table 1.   
RESULTS 
 The literature search identified 21 studies, but only two remained after duplicates 
and irrelevant studies were excluded. The two studies in this systematic review, Barnhart 
et al9 and Davis et al,10 are both follow-up studies of a phase 3 contraceptive trial. The 
phase 3 trial7 evaluated the safety and efficacy of a continuous daily regimen of a low 
dose combination oral contraceptive. This open-label study was conducted at 92 medical 
centers in North America between February 2003 and September 2004. The COC utilized 
in this trial was 90 mcg of levonorgesterel (LNG) and 20 mcg of ethinyl estradiol (EE). 
The trial included healthy women between 18 and 49 years of age who were sexually 
active and likely to become pregnant. Moreover, these women had regular menstrual 
cycles lasting 21-35 days for the three months preceding the trial. The exclusion criteria 
in the phase 3 trial involved the standard contraindications for oral contraceptive use and 
the use of medications that could interfere with the efficacy of the oral contraceptive.7 
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 The phase 3 contraceptive trial’s follow-up studies by Barnhart et al9 and Davis et 
al10 evaluated the return to fertility after the cessation of continuous COC use. Table 2 
illustrates the summary of findings from these two studies.  
Barnhart et al 
 From the phase 3 contraceptive trial,7 34 women who had stopped continuous 
COC treatment due to the intention of becoming pregnant were qualified for this follow-
up study.9 Out of these 34 women, 21 subjects actually underwent the study. In this 
prospective, observational study, there was no control group for comparison. For the 21 
participants, the mean duration of continuous COC treatment was 197 days, 
approximately 6.6 months.9   
The primary endpoint examined was the return to fertility measured by the 
pregnancy rate within 12 months after the cessation of continuous COC. The participants 
were contacted by phone at 3 months and then at 12 months for the pregnancy status. For 
the 21 participants, the pregnancy rate at 3 months was 57% and at 12 months was 81%. 
Figure 1 shows the survival function estimating the time to return to fertility. A total of 
18 participants became pregnant which resulted in 17 live births and 1 spontaneous 
abortion. This study concluded that the pregnancy rate after the cessation of continuous 
COC is comparable to the pregnancy rate after the cessation of traditional cyclic COC. Of 
the 3 participants who did not become pregnant within 12 months, 1 had stopped trying to 
become pregnant and 2 were lost to follow-up.9   
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Davis et al 
 In this prospective, observational follow-up study10 of the phase 3 contraceptive 
trial,7 the participants who had taken COC continuously for at least 6 months were 
included. After the cessation of continuous COC, women who were using non-hormonal 
contraceptives (primarily condoms) or those seeking to become pregnant were eligible. 
The exclusion criteria involved intra-uterine or hormonal contraceptive use and women 
older than 35 years of age who smoked more than 15 cigarettes per day. There was no 
control group for comparison. Of the198 subjects enrolled in the study, 187 completed 
the study, 7 were lost to follow-up, and 4 were excluded for protocol violation. For the 
187 participants, the mean duration of continuous COC treatment was 349 days, 
approximately 11.6 months.10 
 The primary endpoint measured by the authors was the time to return to 
spontaneous menses or pregnancy after the cessation of continuous COC. “Spontaneous 
menses” was defined as at least 2 consecutive days of bleeding requiring sanitary 
protection. The authors inferred that the spontaneous menses were post-ovulatory and 
utilized the occurrence of menses as an indication for return to fertility. The subjects 
recorded in daily diary cards the occurrences of spontaneous menses or pregnancy and 
returned the card with these occurrences. For those who did not have either of these 
occurrences by day 90, a post-study visit was conducted where the diaries were collected 
and a serum pregnancy test was performed.10 
 Out of the 187 participants, 185 (98.9%) had return of spontaneous menses or 
were pregnant within 90 days, or 3 months, following the cessation of continuous COC 
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use. In Figure 2, the survival function estimating the time to return to spontaneous 
menses or pregnancy is shown. Of these 185 subjects, 181 had spontaneous menses and 4 
were pregnant. The median time to spontaneous menses was 32 days, or 1 month. Out of 
4 women who were pregnant, 3 had full-term babies and 1 was lost to follow-up. Two 
participants did not have menses by day 90.10  
 The authors also examined the length of amenorrhea induced by continuous COC 
use and the time to return of menses and found no association between the two. The 
amenorrhea produced by continuous COC use appears to be readily reversible regardless 
of the duration of amenorrhea.10  
DISCUSSION 
This systematic review appraised the current research on the effect of continuous 
COC use on subsequent fertility in healthy women of child-bearing age. The two 
included studies9,10 suggest that continuous COC use does not delay the return to fertility. 
The congruity of the results adds one positive characteristic to the overall quality of the 
studies. However, these two studies possessed major flaws in numerous areas as 
discussed below, that whether continuous COC use does not have any negative impact on 
subsequent fertility cannot be established with certainty.   
The most significant flaw is the lack of control group for comparison in both 
studies, thus causing serious limitation in the methodology and serious inconsistency of 
the results. The participants in Barnhart et al9 were 21 women who had ceased continuous 
COC from the phase 3 trial to attempt to achieve pregnancy and for these women, the 
pregnancy rate was 81% at 12 months post treatment. Barnhart et al9 compared this 
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pregnancy rate to the 84% pregnancy rate at 12 months post treatment with the traditional 
cyclic COC found in another study.11 In Davis et al,10 the subjects were 187 women from 
the phase 3 trial who had at least 6 months of continuous COC treatment and 98.9% of 
these women had spontaneous return of menses or pregnancy within 3 months of 
treatment discontinuation. There was no comparison group to contrast the time of 
spontaneous return of menses or pregnancy after cessation of the traditional cyclic COC. 
The lack of control groups limited their methodologies making it likely to result in biased 
assessment of the treatment effect. Furthermore, it also made it impossible to determine if 
the results were consistent.    
Additionally, in Davis et al,10 the time to fertility was evaluated for women who 
may not have necessarily wanted to become pregnant, further degrading their 
methodology. The inclusion criteria allowed women with at least 6 months of previous 
continuous COC treatment, who then were using non-hormonal contraceptives or were 
seeking to become pregnant. The article does not explicitly identify how many of the 187 
participants were using non-hormonal contraceptives vs. seeking to become pregnant. 
Therefore, it is difficult to decipher if the 4 out of 187 women who became pregnant in 
this study were the only women who desired pregnancy and if the 181 women who had 
spontaneous menses were the ones using non-hormonal contraceptives.  
Another major flaw is the indirectness of evidence in Davis et al.10 The authors of 
this study utilized the occurrence of spontaneous menses along with the time to 
pregnancy as a measure of return to fertility. They assumed that the occurrence of first 
menses was an indication for ovulation10; yet, the bleeding could have resulted from the 
withdrawal of COC hormones and not necessarily from the post-ovulatory endometrial 
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shedding. In fact, this very mechanism is how COC works: ovulation is inhibited by the 
hormone use, and the bleeding during a traditional cyclic COC placebo period is due to 
the withdrawal of hormones. So when a woman has been using combination oral 
contraceptives, whether continuously or in the typical cyclic 28-day fashion, then stops 
taking them, it is the withdrawal of hormones that typically causes the bleeding. Right 
now, return to fertility is truly best estimated by the time to pregnancy, not by the time to 
return to spontaneous menses. Davis et al10 used the time to the occurrence of 
spontaneous menses as a surrogate outcome, and thereby minimized the directness of 
their evidence.  
Fourthly, it must also be noted that the mean duration of continuous COC 
treatment was very short in both studies, making it difficult to postulate the effect of 
long-term continuous COC use on return to fertility. Women were treated for the mean 
duration of 6.6 months in Barnhart et al9 and 11.6 months in Davis et al.10 Davis et al10 
concluded that the duration of amenorrhea induced by continuous COC use is unrelated 
to the time to return of menses, yet the maximum duration of continuous COC treatment 
in this study was merely 13 months.  
 The fifth key limitation is the small sample size in Barnhart et al9 and Davis et 
al,10 thus inducing some imprecision overall.  Barnhart et al9 had a total of 21 participants 
and Davis et al10 had 187 subjects who completed the study. These were both follow-up 
studies from the same large phase 3 contraceptive trial7 and the small sample size was 
probably not modifiable.  
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Lastly, in examination of other possible biases, it was discovered that Wyeth 
Research, the manufacturer of Lydrel, the drug utilized in both studies, sponsored 
Barnhart et al9 and Davis et al.10 The results from both studies suggest that Lydrel, the 
continuous COC containing LNG and EE, does not negatively impact the return to 
fertility.9,10 Due to these positive findings for the drug, the probability for publication bias 
in both studies cannot be eliminated.   
The quality of evidence in both Barnhart et al9 and Davis et al10 are very low. But 
the result from each study appears to suggest that continuous COC does not negatively 
impact the subsequent fertility. Thus, more extensive research of high quality evidence is 
crucial.  
The next step in ascertaining whether the previous use of continuous COC delays 
the return to fertility is to conduct a prospective, cohort study of healthy women of child-
bearing age desiring pregnancy in the future with no previous history of COC use. The 
control group will be on no method of contraception, while the experimental group will 
be placed on continuous COC for at least 6 months. For the control group, the time to 
pregnancy will be measured from the study initiation and for the experimental group, the 
time to pregnancy will be measured from the time of treatment discontinuation. It is vital 
to have a control group for comparison in order to eliminate the limitations of the 
methodology as well as to minimize the inconsistency of the results. Large sample size is 
also recommended to improve the precision of the study. Prolonged continuous COC 
treatment lasting more than several years should also be considered to provide long-term 
effect on return to fertility.  
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For healthy women who are seeking to try continuous COC as a contraceptive 
method, the clinicians need to inform them about the limitations of the current research. 
Continuous COC does induce amenorrhea in most women5 and this could be 
advantageous for some desiring to have less frequent menstruations and related 
symptoms, as well as lifestyle benefits and convenience. While continuous COC does 
have a good safety and efficacy profile comparable to the traditional cyclic COC,7 its 
effect on subsequent fertility needs further research.  
CONCLUSION 
Combination oral contraceptive is the leading method of contraception utilized in 
the United States. The traditional 28-day cyclic COC has been the standard COC 
prescribed due to its naturalness and acceptance by women. Yet, the newly developed 
continuous COC may provide superior benefits for women by reducing the frequency of 
menses and severity of related symptoms and offering lifestyle benefits and convenience.  
Based on a large phase 3 contraceptive trial, continuous COC has a good safety 
and efficacy profile comparable to the traditional cyclic COC. Recent studies suggest that 
the pregnancy rate after continuous COC use is similar to the pregnancy rate after the 
traditional cyclic COC use. The amenorrhea induced by continuous COC use also seems 
to be readily reversible regardless of the duration of amenorrhea. However, more high 
quality research is necessary to determine the effect of continuous COC use on the 
subsequent fertility. Presently, women should be educated about the limitations of current 
research and encouraged to make their own decisions in choosing continuous COC as a 
contraceptive method. 
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Figure 1. Time to return to fertility  
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Figure 2. Time to return to spontaneous menses or 
pregnancy 
 
 
